Neovasc Inc. is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Neovasc Reducer™ for the treatment of refractory angina, the Tiara™ technology in development for the transcatheter treatment of mitral valve disease and a line of advanced biological tissue products that are used as key components in a variety of third-party medical products, such as vascular surgical patches and transcatheter heart valves.
Company Growth (employees)
Richmond, CA
Size (employees)
147 (est)-25%
Neovasc was founded in 2008 and is headquartered in Richmond, CA

Key People/Management at Neovasc

Alexei Marko

Alexei Marko

CEO & Director
Christopher Clark

Christopher Clark

Brian McPherson

Brian McPherson


Neovasc Office Locations

Neovasc has an office in Richmond
Richmond, CA (HQ)
5138 13562 Maycrest Way
Show all (1)

Neovasc Financials and Metrics

Neovasc Financials


Market capitalization (19-Oct-2017)

122.3 m

Closing share price (19-Oct-2017)

Neovasc's current market capitalization is $122.3 m.
Show all financial metrics

Neovasc Market Value History

Neovasc's Web-traffic and Trends

Neovasc Online and Social Media Presence

Neovasc Company Life and Culture

You may also be interested in